(Q70794213)
Statements
Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients (English)
S Albitar
Q Meulders
H Hammoud
C Soutif
P Bouvier
scientific article published on 01 January 1995